The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial Fibrillation

Background/Aims: The role of the β3-adrenergic receptor (β3-AR) agonist BRL37344 in atrial fibrillation (AF) structural remodeling and the underlying mechanisms as a therapeutic target were investigated. Methods: Four groups of dogs were evaluated: sham, pacing, β3-AR agonist BRL37344 (β3-AGO), and...

Full description

Bibliographic Details
Main Authors: Xiaobing Wang, Ruifeng Wang, Guangzhong Liu, Jingmei Dong, Guanqi Zhao, Jingpu Tian, Jiayu Sun, Xiuyue Jia, Lin Wei, Yuping Wang, Weimin Li
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2016-02-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:http://www.karger.com/Article/FullText/438647
id doaj-9317be59bf284c729cc616a7d307450b
record_format Article
spelling doaj-9317be59bf284c729cc616a7d307450b2020-11-25T00:11:01ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782016-02-0138251453010.1159/000438647438647The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial FibrillationXiaobing WangRuifeng WangGuangzhong LiuJingmei DongGuanqi ZhaoJingpu TianJiayu SunXiuyue JiaLin WeiYuping WangWeimin LiBackground/Aims: The role of the β3-adrenergic receptor (β3-AR) agonist BRL37344 in atrial fibrillation (AF) structural remodeling and the underlying mechanisms as a therapeutic target were investigated. Methods: Four groups of dogs were evaluated: sham, pacing, β3-AR agonist BRL37344 (β3-AGO), and β3-AR antagonist L748337 (β3-ANT) groups. Dogs in the pacing, β3-AGO and β3-ANT groups were subjected to rapid atrial pacing for four weeks. Atrial structure and function, AF inducibility and duration, atrial myocyte apoptosis and interstitial fibrosis were assessed. Atrial superoxide anions were evaluated by fluorescence microscopy and colorimetric assays. Cardiac nitrate+nitrite levels were used to assess nitric oxide (NO) production. Protein and mRNA expression of β3-AR, neuronal NO synthase (nNOS), inducible NO synthase (iNOS), endothelial NO synthase (eNOS) and guanosine triphosphate cyclohydrolase-1 (GCH-1) as well as tetrahydrobiopterin (BH4) levels were measured. Results: β3-AR was up-regulated in AF. Stimulation of β3-AR significantly increased atrial myocyte apoptosis, fibrosis and atrial dilatation, resulting in increased AF induction and prolonged duration. These effects were attenuated by β3-ANT. Moreover, β3-AGO reduced BH4 and NO production and increased superoxide production, which was inhibited by the specific iNOS inhibitor, 1400w β3-AGO also increased iNOS but decreased eNOS and had no effect on nNOS expression in AF. Conclusions: β3-AR stimulation resulted in atrial structural remodeling by increasing iNOS uncoupling and related oxidative stress. β3-AR up-regulation and iNOS uncoupling might be underlying AF therapeutic targets.http://www.karger.com/Article/FullText/438647Atrial fibrillationβ3-adrenergic receptorAtrial structural remodelingOxidative stressNitric oxide synthaseTetrahydrobiopterin
collection DOAJ
language English
format Article
sources DOAJ
author Xiaobing Wang
Ruifeng Wang
Guangzhong Liu
Jingmei Dong
Guanqi Zhao
Jingpu Tian
Jiayu Sun
Xiuyue Jia
Lin Wei
Yuping Wang
Weimin Li
spellingShingle Xiaobing Wang
Ruifeng Wang
Guangzhong Liu
Jingmei Dong
Guanqi Zhao
Jingpu Tian
Jiayu Sun
Xiuyue Jia
Lin Wei
Yuping Wang
Weimin Li
The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial Fibrillation
Cellular Physiology and Biochemistry
Atrial fibrillation
β3-adrenergic receptor
Atrial structural remodeling
Oxidative stress
Nitric oxide synthase
Tetrahydrobiopterin
author_facet Xiaobing Wang
Ruifeng Wang
Guangzhong Liu
Jingmei Dong
Guanqi Zhao
Jingpu Tian
Jiayu Sun
Xiuyue Jia
Lin Wei
Yuping Wang
Weimin Li
author_sort Xiaobing Wang
title The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial Fibrillation
title_short The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial Fibrillation
title_full The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial Fibrillation
title_fullStr The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial Fibrillation
title_full_unstemmed The β3 Adrenergic Receptor Agonist BRL37344 Exacerbates Atrial Structural Remodeling Through iNOS Uncoupling in Canine Models of Atrial Fibrillation
title_sort β3 adrenergic receptor agonist brl37344 exacerbates atrial structural remodeling through inos uncoupling in canine models of atrial fibrillation
publisher Cell Physiol Biochem Press GmbH & Co KG
series Cellular Physiology and Biochemistry
issn 1015-8987
1421-9778
publishDate 2016-02-01
description Background/Aims: The role of the β3-adrenergic receptor (β3-AR) agonist BRL37344 in atrial fibrillation (AF) structural remodeling and the underlying mechanisms as a therapeutic target were investigated. Methods: Four groups of dogs were evaluated: sham, pacing, β3-AR agonist BRL37344 (β3-AGO), and β3-AR antagonist L748337 (β3-ANT) groups. Dogs in the pacing, β3-AGO and β3-ANT groups were subjected to rapid atrial pacing for four weeks. Atrial structure and function, AF inducibility and duration, atrial myocyte apoptosis and interstitial fibrosis were assessed. Atrial superoxide anions were evaluated by fluorescence microscopy and colorimetric assays. Cardiac nitrate+nitrite levels were used to assess nitric oxide (NO) production. Protein and mRNA expression of β3-AR, neuronal NO synthase (nNOS), inducible NO synthase (iNOS), endothelial NO synthase (eNOS) and guanosine triphosphate cyclohydrolase-1 (GCH-1) as well as tetrahydrobiopterin (BH4) levels were measured. Results: β3-AR was up-regulated in AF. Stimulation of β3-AR significantly increased atrial myocyte apoptosis, fibrosis and atrial dilatation, resulting in increased AF induction and prolonged duration. These effects were attenuated by β3-ANT. Moreover, β3-AGO reduced BH4 and NO production and increased superoxide production, which was inhibited by the specific iNOS inhibitor, 1400w β3-AGO also increased iNOS but decreased eNOS and had no effect on nNOS expression in AF. Conclusions: β3-AR stimulation resulted in atrial structural remodeling by increasing iNOS uncoupling and related oxidative stress. β3-AR up-regulation and iNOS uncoupling might be underlying AF therapeutic targets.
topic Atrial fibrillation
β3-adrenergic receptor
Atrial structural remodeling
Oxidative stress
Nitric oxide synthase
Tetrahydrobiopterin
url http://www.karger.com/Article/FullText/438647
work_keys_str_mv AT xiaobingwang theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT ruifengwang theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT guangzhongliu theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT jingmeidong theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT guanqizhao theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT jingputian theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT jiayusun theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT xiuyuejia theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT linwei theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT yupingwang theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT weiminli theb3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT xiaobingwang b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT ruifengwang b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT guangzhongliu b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT jingmeidong b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT guanqizhao b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT jingputian b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT jiayusun b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT xiuyuejia b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT linwei b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT yupingwang b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
AT weiminli b3adrenergicreceptoragonistbrl37344exacerbatesatrialstructuralremodelingthroughinosuncouplingincaninemodelsofatrialfibrillation
_version_ 1725405637342396416